The USG seeks information from stakeholders on available medical
        countermeasures in development. BARDA is particularly interested in
        products, technologies, and capabilities that have progressed into or
        beyond clinical trials, have established large-scale cGMP manufacturing
        capability, or utilize an approved platform.
      
      
      
      These requests are for market research purposes only and are not
        considered submissions for potential funding.
      
  
   
		
 
                 
     
  

